Fig. 21From: Synthesis, DFT and molecular docking of novel (Z)-4-bromo-N-(4-butyl-3 (quinolin-3-yl)thiazol-2(3H)-ylidene)benzamide as elastase inhibitorIllustration of docking protocol validation. Blue ligand is regenerated pose whereas pink ligand is native conformation (RMSD 2.3 angstroms)Back to article page